OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-SPR antibodies

Anti-SPR CAPTURE Antibody Clone OTI3D6

div

Specifications Citations (0) Related Products Product Documents
SKU Description Amount Price Availability*  
TA600129 Elisa and Luminex Validated and SPR mouse monoclonal antibody (clone 3D6, clone OTI3D6 (formerly 3D6) 100ug $325 2 Weeks
Matched Antibody
  • ELISA and Luminex validated biotinylated SPR mouse monoclonal antibody (clone 3C8), clone OTI3C8 (formerly 3C8), 50 ug
TA700127 $345 2 Weeks Add to Shopping Cart
Add to Shopping Cart

spacer
LMNX(1)
ELISA(1)

OriGene Data

ImmunogenFull length human recombinant protein of human SPR (NP_003115) produced in HEK293T cell.
Clone NameClone OTI3D6 IsotypeIgG1
Species ReactivityHuman Concentration0.5 mg/ml
Guaranteed Application *ELISA, LMNX Suggested Dilutions1:100 - 1:1000
BufferStored in PBS (pH 7.4) containing 0.05% sodium azide and up to 5% trehalose

Reference Data

Target NameHomo sapiens sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) (SPR)
Alternative NameSDR38C1
Database LinkNP_003115
Entrez Gene 6697 Human
Function
Related PathwayDruggable Genome Folate biosynthesisMetabolic pathways

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

SPR ELISA with 3D6 Capture (TA600129) and 3C8 Detection (TA700127) Antibodies. Substrate used: Recombinant Human SPR (TP305679)
spacer
SPR Luminex with 3D6 Capture (TA600129) and 3C8 Detection (TA700127) Antibodies. Substrate used: Recombinant Human SPR (TP305679)
spacer

 

spacer
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title